InsidersTradesSigma
Follow the HUM share price and the full insider trade history of the company, a publicly traded company based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Healthcare & Pharma sector, HUM has published 4 insider filings. Market capitalisation: €232.3m. The latest transaction was filed on 14 May 2026 (Other). Among the most active insiders: substantial holder on 13 / 05 / 2026. Every trade is accessible without an account.
4
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,380 of 29,064 companies
57.0
score / 100
Value71
Quality44
FCF yld32%
Earn yld7.2%
EV/EBITDA14.7x
ROE3.0%
Gross mgn96%
Net mgn2.5%
Debt/EBITDA14.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 May 2026
Declarations4 total
ShareASXASX:2924-03090173-2A1672112
ShareASXASX:2924-03090172-2A1672111
ShareASXASX:2924-03090146-2A1672095
ShareASXASX:2924-03090145-2A1672094
4 of 4 declarations
关于 HUM
HUM 是一家在 XASX 市场上市的健康和制药公司。它专注于开发和商业化创新解决方案，以改善患者健康。
